Scanroof Life Sciences Private Limited, a active private limited company, was established on 20 October 2016 in Bangalore, Karnataka, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U74999KA2016PTC097264. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Formerly known as Meddworld Life Sciences Private Limited. It upholds a compliant status. Its leadership includes Naveen Ramegowda Bikkalahalli (Director), Munawar Neena (Director). Past directors included Sudhakar Sampangi, Radhamma Subramani, Chandan Krishnappa. It holds ₹7.74 M open charges and no settled loans. Its latest AGM occurred on 28 September 2023, with the balance sheet filed on 31 March 2023. It is based at No 3/1, Ground Floor, 1St Cross, Gangappa Block, Ganganagar, Bangalore, Karnataka, 560032.
U74999KA2016PTC097264
097264
20 October 2016
₹0.50 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Scanroof Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveen Ramegowda Bikkalahalli | Director | 20 Oct 2016 | Current |
| Munawar Neena | Director | 03 Mar 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Jul 2017 | Past |
| Pramod Abcsdd | Director | 04 Feb 2021 | Past |
| Pramod Abcsdd | Director | 20 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Scanroof Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 174.74% increase. The company also saw a substantial improvement in profitability, with a 137.76% increase in profit. The company's net worth Soared by an impressive increase of 37.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Scanroof Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹7,739,130.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2017 | Others | ₹2.50 M | Open |
| 20 Jan 2017 | Others | ₹2.03 M | Open |
| 20 Jan 2017 | Others | ₹1.22 M | Open |
| 20 Jan 2017 | Others | ₹1.99 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Scanroof Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Scanroof Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scanroof Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Scanroof Life Sciences Private Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records. was completed.
The activity Scanroof Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.
Munawar Neena was appointed as a Director was appointed as a Director on 03 Mar 2023 & has been associated with this company since 2 years 9 months . was recorded as a recent event.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100085030 was registered on 15 Mar 2017. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.03 M with Charge ID 100084083 was registered on 20 Jan 2017. was documented.
A charge with Others amounted to Rs. 1.22 M with Charge ID 100084090 was registered on 20 Jan 2017. was recorded as a recent event.
The CIN of Scanroof Life Sciences Private Limited is U74999KA2016PTC097264.
Scanroof Life Sciences Private Limited is headquartered at No 3/1, Ground Floor, 1St Cross, Gangappa Block, Ganganagar, Bangalore, Karnataka, 560032.
Scanroof Life Sciences Private Limited was incorporated on 20 October 2016.
The current directors of Scanroof Life Sciences Private Limited are
The primary industry of Scanroof Life Sciences Private Limited is Hospital And Medical Care.
Scanroof Life Sciences Private Limited is unlisted.
The authorized capital of Scanroof Life Sciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Scanroof Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX